UCB - Ebit

Stock Price
254.90
Daily Change
5.30 2.12%
Monthly
-10.09%
Yearly
37.82%
Q1 Forecast
243.41

UCB reported EUR502M in EBIT for its fiscal semester ending in December of 2024.





Ebit Change Date
Alcon AG USD 317M 17M Dec/2025
Almirall EUR 30.23M 12.8M Dec/2025
Amarin USD -1.7M 8.47M Sep/2025
argenx SE USD 371.14M 21.17M Dec/2025
AstraZeneca USD 2.97B 4.48B Dec/2025
Bayer EUR 1.11B 1.51B Dec/2025
Galapagos EUR 780.56M 822.23M Dec/2025
Genmab DKK 432M 900.27M Jun/2025
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
GRIFOLS EUR 352.11M 20.18M Sep/2025
Hikma Pharmaceutical USD 348M 31M Dec/2025
Lonza CHF 673M 54M Jun/2025
Merck EUR 474M 738M Dec/2025
Novartis USD -9.19B 13.87B Jun/2025
Orion EUR 328.1M 207.1M Dec/2025
Recordati EUR 278.23M 112.58M Dec/2025
Roche Holding CHF 9.56B 2.1B Dec/2025
Sanofi EUR 1.7B 2.17B Dec/2025
UCB EUR 502M 168M Dec/2024
Unibail Rodamco EUR 1.13B 41.8M Dec/2024